Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (921)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2025 (publication date) through May 5, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Heymann G, Rahman S, Kats D, Banini BA, Gaddam S, Aslanian E, Boateng S, Israel G, Muniraj T. Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2025; 31(47): 114651 [PMID: 41479758 DOI: 10.3748/wjg.v31.i47.114651] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Heymann G, Rahman S, Kats D, Banini BA, Gaddam S, Aslanian E, Boateng S, Israel G, Muniraj T. Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2025; 31(47): 114651 [PMID: 41479758 DOI: 10.3748/wjg.v31.i47.114651] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v31/i47/114651.htm |
| Number | Citing Articles |
| 1 |
志君 李. Association between Metabolic Dysfunction-Related Fatty Liver Disease (MASLD) and Colorectal Cancer: A Comprehensive Review of Diagnosis and Disease Progression. Advances in Clinical Medicine 2026; 16(02): 1402 doi: 10.12677/acm.2026.162527
|
| 2 |
Stanislav Kotlyarov. Crosstalk between non-alcoholic fatty pancreas disease and metabolic dysfunction-associated steatotic liver disease: Immunometabolic interactions and clinical implications. World Journal of Gastroenterology 2026; 32(15): 116406 doi: 10.3748/wjg.v32.i15.116406
|